By embracing practical, human-centered use cases, life sciences companies are breaking free from GenAI “pilotitis” and demonstrating how scalable AI solutions can help transform patient care and provider efficiency.
Dan Schulman
Advertisement
Articles by Dan Schulman
Advertisement
Latest Updated Articles
Innovation with GenAI: Lessons from Life Sciences and BeyondApril 18th 2025
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Why Some Employers Are Scaling Back GLP-1 Coverage in 2027
2
Pharma Pulse: A Surge In Drug Discontinuations and Unapproved Retatrutide Prescriptions
3
Simplifying and Improving Global Pharma Operations
4
How Automation and AI Transform Pharmacovigilance
5